Characterisation of acute murine dextran sodium sulphate colitis: Cytokine profile and dose dependency

Digestion

Volumn 62, Issue 4, 2000, Pages 240-248

  Egger, Bernhard ^a   Bajaj Elliott, Mona ^b   Macdonald, Thomas T ^b   Inglin, Roman ^a   Eysselein, Viktor E ^c   Büchler, Markus W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Acute dextran sulphate colitis; Colitis model; Concentration; Cytokine response; Effective dose; Inflammatory bowel disease; Mucosal injury

Indexed keywords

DEXTRAN SULFATE; SODIUM SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; COLON MUCOSA; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG EFFECT; DRUG INDUCED DISEASE; ENTERITIS; FLUID INTAKE; LAMINA PROPRIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0033768784     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007822     Document Type: Article

References (40)

1. Animal models of inflammatory bowel disease and colon cancer
2. Experimental models for ulcerative colitis
3. Experimental models of inflammatory bowel disease
4. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice
5. Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes
6. Time course of immunological events in dextran sulfate sodium-induced colitis in rats: An immunohistochemical and ultrastructural study
7. Involvement of CD4+ T cells in the development of dextran sulfate sodium-induced experimental colitis and suppressive effect of IgG on their action
8. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice
9. Chronic experimental colitis induced by dextran sulphate sodium is characterized by Th1 and Th2 cytokines
10. Clinicopathologic study of dextran sulfate sodium experimental murine colitis
11. Hemodynamics in the colonic mucosa of rats with dextran sulfate-induced colitis in the early phase
12. Selective uptake of intraluminal dextran sulfate sodium and senna by macrophages in the cecal mucosa of the guinea pig
13. Morphological analysis of acute ulcerative colitis experimentally induced by dextran sulfate sodium in the guinea pig: Some possible mechanisms of cecal ulceration
14. Study on the experimental ulcerative colitis model induced by dextran sulfate sodium in rats: Estimation of mucosal erosions by the alcian blue-staining method
15. Immunological effect of immunoglobulin on experimental colitis induced by dextran sulfate
16. Involvement of interleukin-1 in the development of ulcerative colitis induced by dextran sulfate sodium in mice
17. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor
18. Dextran sulfate sodium-induced experimental colitis in immunodeficient mice: Effects in CD4(+) -cell depleted, athymic and NK-cell depleted SCID mice
19. Mice lacking transforming growth factor-alpha have an increased susceptibility to dextran sulfate-induced colitis
20. Reduced susceptibility of mice overexpressing transforming growth factor-alpha to dextran sodium sulphate-induced colitis
21. Melatonin reduces the severity of dextran-induced colitis in mice
22. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin
23. Keratinocyte growth factor ameliorates dextran sodium sulfate colitis in mice
24. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis
25. Cytokines in inflammatory bowel disease
26. The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease
27. Circulating anti-inflammatory cytokine IL-10 in patients with inflammatory bowel disease
28. Assessment of in vivo activated T cells in patients with Crohn's disease
29. Intestinal immune reactivity to interleukin-2 differs among Crohn's disease, ulcerative colitis, and controls
30. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease
31. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease
32. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction
33. Potentiation of tachykinin-induced plasma protein extravasation by calcitonin gene-related peptide
34. Genetically resistant (Ityr) and susceptible (Itys) congenic mouse strains show similar cytokine responses following infection with Salmonella dublin
35. Interferon-gamma- and tumour necrosis factor-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium-induced colitis in mice
36. Neutralization of tumour necrosis factor but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice
37. Interleukin-4 in inflammatory bowel disease and mucosal immune reactivity
38. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
39. Interleukin-10
40. Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease